
Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
Avicanna talks medical pot real-world evidence study
Avicanna Announces Medical Cannabis Real World Evidence Results and Publication
Cresco Labs Establishes At-the-Market Offering
Trulieve closes $60-million (U.S.) note offering
High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA
Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science
Functional Wellness Stocks Explode as $179 Billion Beverage Market Ditches Sugar for Science
Trulieve Announces Closing of US$60 Million Private Placement of 10.5% Senior Secured Notes
Nextleaf Reports Fiscal Year 2025 Financial Performance
Cannara Announces Conditional Approval to List on the Toronto Stock Exchange
Vireo Growth Inc. Enters into Non-Binding Memorandum of Understanding to Acquire The Hawthorne Gardening Company from ScottsMiracle-Gro
Biomind arranges $2.52-million private placement
MTL Cannabis mails info circular for special meeting
Biomind Labs Announces CAD $2.52 Million Private Placement Financing